Long-Term Assets: The sum of all assets classified as non-current.
Amarantus Bioscience Holdings Inc. (AMBS) had Long-Term Assets of $10.92M for the most recently reported fiscal quarter, ending 2016-03-31.
| Income Statement Financials | |
-- |
|
$-12.63M |
|
-- |
|
-- |
|
$2.65M |
|
$-2.65M |
|
$1.08M |
|
$-1.58M |
|
$-1.58M |
|
$-1.58M |
|
$-1.58M |
|
$-1.58M |
|
$-1.58M |
|
$-2.65M |
|
$-1.59M |
|
33.72M |
|
33.72M |
|
$-0.37 |
|
$-0.37 |
|
| Balance Sheet Financials | |
$0.94M |
|
$0.10M |
|
|
Long-Term Assets |
$10.92M |
$11.87M |
|
$15.83M |
|
-- |
|
$21.86M |
|
$37.69M |
|
$-25.83M |
|
$-36.66M |
|
$-25.83M |
|
57.64M |
|
| Cash Flow Statement Financials | |
$-2.49M |
|
$-0.50M |
|
$2.91M |
|
$0.18M |
|
$0.10M |
|
$-0.08M |
|
$0.38M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
0.06 |
|
-- |
|
-- |
|
-- |
|
-0.13 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-2.49M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
6.10% |
|
4.30% |
|
-13.28% |
|
6.10% |
|
$-0.45 |
|
$-0.07 |
|
$-0.07 |
|